SILO PHARMA, INC. Loans Payable
SILO PHARMA, INC. (SILO) had Loans Payable of $42.00 thousand as of 2022-11-27, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:LoansPayable · last filed 2023-08-11
- 2022-11-27: Loans Payable $42.00K.
- 2022-09-28: Loans Payable $42.00K.
- 2022-09-27: Loans Payable $42.00K.
| Period end | Loans Payable |
|---|---|
| 2022-11-27 | $42.00K 10-Q · filed 2022-11-10 |
| 2022-09-28 | $42.00K 10-Q · filed 2023-08-11 |
| 2022-09-27 | $42.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |